Four connected capabilities spanning the evidence lifecycle — from the first literature search through to a defended HTA submission.
We turn a scattered clinical evidence base into a structured, defensible package that answers the questions HTA bodies actually ask — built to submission standard from the outset, not retrofitted afterwards.
Economic models that translate a clinical benefit into a value argument a payer will accept — transparent in their assumptions, robust under scrutiny, and structured so a reviewer can follow every calculation.
Rigorous analysis, framed around the decision it has to support. We work from the trial data upward to produce the estimates a model needs and the evidence a regulator or payer will interrogate.
Submission strategy and delivery across markets, from early pipeline evaluation through launch and beyond — anticipating where an assessment will be challenged, and building the evidence to meet it.
Most engagements draw on more than one of these. Tell us the decision you need to support and we will propose a scope.